Skip to main content
SpringerLink
Log in

Pharmacotherapy of Diabetes: New Developments

Improving Life and Prognosis for Diabetic Patients

  • Book
  • © 2007

Overview

Editors:
  1. Carl Erik Mogensen

    1. Aarhus University Hospital, Denmark

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Provides a comprehensive and invaluable guide to all aspects of the pharmacological treatment of diabetes, covering basic concepts and in-depth review of current and future therapies

  • Includes supplementary material: sn.pub/extras

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (28 chapters)

  1. Front Matter

    Pages i-xv
    Download chapter PDF

  2. Overview

    1. Pharmacoepidemiology of Diabetes

      • Jørgen Rungby, Andrew J. Krentz
      Pages 3-8

    2. New Definitions of Diabetes: Consequences

      • Knut Borch-Johnsen
      Pages 9-16

  3. Pharmacotherapy of Diabetes

    1. The Insulin Resistance Syndrome: Concept and Therapeutic Approaches

      • Gerald M. Reaven
      Pages 19-30

    2. Medical Emergencies – Diabetic Ketoacidosis and Hyperosmolar Hyperglycaemia

      • Niels Møller, K. George M. M. Alberti
      Pages 31-37

    3. Notes on the Use of Glucagon in Type 1 Diabetes

      • Carl Erik Mogensen
      Pages 39-39

    4. Insulin and New Insulin Analogues, Insulin Pumps and Inhaled Insulin in Type 1 Diabetes

      • Kjeld Hermansen
      Pages 41-51

    5. Insulin and New Insulin Analogues with Focus on Type 2 Diabetes

      • Sten Madsbad
      Pages 53-65

    6. The Place of Insulin Secretagogues in the Treatment of Type 2 Diabetes in the Twenty-First Century

      • Harald Stingl, Guntram Schernthaner
      Pages 67-76

    7. Metformin – from Devil to Angel

      • Guntram Schernthaner, Gerit Holger Schernthaner
      Pages 77-86

    8. The Glitazones, Lessons so Far

      • Monika Shirodkar, Serge Jabbour
      Pages 87-97

    9. Antidiabetic Combination Therapy

      • Henning Beck-Nielsen, Jan Erik Henriksen
      Pages 99-109

    10. The Incretin Modulators – Incretin Mimetics (GLP-1 Receptor Agonists) and Incretin Enhancers (DPP-4 Inhibitors)

      • Michael A. Nauck, Wolfgang E. Schmidt, Juris J. Meier
      Pages 111-141

    11. The Role of Alpha-Glucosidase Inhibitors (Acarbose)

      • Markolf Hanefeld, Frank Schaper
      Pages 143-152

    12. Multifactorial Intervention in Type 2 Diabetes

      • Oluf Pedersen
      Pages 153-163

  4. Treating the Comorbid Patient

    1. Obesity and Pharmacological Treatment

      • Bjørn Richelsen
      Pages 167-171

    2. Management of Diabetic Dyslipidaemia

      • D. John Betteridge
      Pages 173-186

    3. Coronary Intervention and Ischemic Cardioprotection in Diabetic Patients

      • Torsten Toftegaard Nielsen
      Pages 187-197
Back to top

Keywords

About this book

In the United States, 20.8 million children and adults, 7% of the population, have diabetes. While an estimated 14.6 million have been diagnosed, 6.2 million have yet to be diagnosed. Worldwide diabetes afflicts 150 million people. The World Health Organization estimates that by 2025 that figure will double. Diabetes is responsible for more deaths than AIDS and breast cancer, combined. It is a leading cause of blindness, kidney failure, amputations, heart complications and stroke.

Treatment of Type 1 and Type diabetes has changed radically over the past few years. There are new opportunities for treating the key abnormality in diabetes, increased blood glucose, by effective agents such as new insulin preparations and oral agents.

Increasing so-called non-glycemic intervention is of prime importance. Blood pressure lowering therapies, anti-cholesterol strategies, and specific treatment related to complications is becoming increasingly important.

Pharmacotherapy of Diabetes is a unique, invaluable guide to all aspects of the pharmacological treatment of diabetes, covering basic concepts and an in-depth review of current and future therapies. This work provides an overview for the new changes in therapies that can be implemented in clinical practice and treatment of the diabetic patient.

Editors and Affiliations

  • Aarhus University Hospital, Denmark

    Carl Erik Mogensen

Bibliographic Information

  • Book Title: Pharmacotherapy of Diabetes: New Developments

  • Book Subtitle: Improving Life and Prognosis for Diabetic Patients

  • Editors: Carl Erik Mogensen

  • DOI: https://doi.org/10.1007/978-0-387-69737-6

  • Publisher: Springer New York, NY

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer-Verlag US 2007

  • Hardcover ISBN: 978-0-387-69736-9Published: 05 September 2007

  • Softcover ISBN: 978-1-4419-4345-3Published: 04 November 2010

  • eBook ISBN: 978-0-387-69737-6Published: 23 October 2007

  • Edition Number: 1

  • Number of Pages: X, 289

  • Number of Illustrations: 45 b/w illustrations

  • Topics: Diabetes, Endocrinology

Publish with us

Policies and ethics

Back to top

Search

Navigation